Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 23973508)

1.

Effects of mycophenolic acid-glucosamine conjugates on the base of kidney targeted drug delivery.

Wang X, Lin Y, Zeng Y, Sun X, Gong T, Zhang Z.

Int J Pharm. 2013 Nov 1;456(1):223-34. doi: 10.1016/j.ijpharm.2013.07.064. Epub 2013 Aug 21.

PMID:
23973508
2.

Targeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamine.

Lin Y, Li Y, Wang X, Gong T, Zhang L, Sun X.

J Control Release. 2013 Apr 28;167(2):148-56. doi: 10.1016/j.jconrel.2013.02.001. Epub 2013 Feb 13.

PMID:
23415893
3.

Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan.

Yuan ZX, Zhang ZR, Zhu D, Sun X, Gong T, Liu J, Luan CT.

Mol Pharm. 2009 Jan-Feb;6(1):305-14. doi: 10.1021/mp800078a.

PMID:
19035784
4.

Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.

Jiang S, Tang Q, Rong R, Tang L, Xu M, Lu J, Jia Y, Ooi Y, Hou J, Guo J, Yang B, Zhu T.

Eur J Pharmacol. 2012 Aug 5;688(1-3):56-61. doi: 10.1016/j.ejphar.2012.05.001. Epub 2012 May 16.

PMID:
22609232
5.

Mycophenolate mofetil attenuates renal ischemia/reperfusion injury.

Ventura CG, Coimbra TM, de Campos SB, de Castro I, Yu L, Seguro AC.

J Am Soc Nephrol. 2002 Oct;13(10):2524-33.

6.

Mechanistic studies of a novel mycophenolic acid-glucosamine conjugate that attenuates renal ischemia/reperfusion injury in rat.

Wang X, Xiong M, Zeng Y, Sun X, Gong T, Zhang Z.

Mol Pharm. 2014 Oct 6;11(10):3503-14. doi: 10.1021/mp500282g. Epub 2014 Aug 25.

PMID:
25153320
7.

Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.

Han S, Quach T, Hu L, Wahab A, Charman WN, Stella VJ, Trevaskis NL, Simpson JS, Porter CJ.

J Control Release. 2014 Mar 10;177:1-10. doi: 10.1016/j.jconrel.2013.12.031. Epub 2014 Jan 5.

PMID:
24398334
8.

Atrial natriuretic peptide enhances recovery from ischemia/reperfusion-induced renal injury in rats.

Chujo K, Ueno M, Asaga T, Sakamoto H, Shirakami G, Ueki M.

J Biosci Bioeng. 2010 Jun;109(6):526-30. doi: 10.1016/j.jbiosc.2009.11.021. Epub 2009 Dec 23.

PMID:
20471588
9.

Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.

Musuamba FT, Rousseau A, Bosmans JL, Senessael JJ, Cumps J, Marquet P, Wallemacq P, Verbeeck RK.

Clin Pharmacokinet. 2009;48(11):745-58. doi: 10.2165/11318060-000000000-00000.

PMID:
19817503
10.

Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.

Zucker K, Rosen A, Tsaroucha A, de Faria L, Roth D, Ciancio G, Esquenazi V, Burke G, Tzakis A, Miller J.

Transpl Immunol. 1997 Sep;5(3):225-32.

PMID:
9402690
11.
12.

Clinical pharmacokinetics of mycophenolate mofetil.

Bullingham RE, Nicholls AJ, Kamm BR.

Clin Pharmacokinet. 1998 Jun;34(6):429-55. Review.

PMID:
9646007
13.

Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion.

Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Soloski MJ, Crow MT, Rabb H.

Transpl Immunol. 2010 May;23(1-2):45-52. doi: 10.1016/j.trim.2010.04.002. Epub 2010 Apr 20.

PMID:
20412855
14.

Characterization of intestinal absorption and enterohepatic circulation of mycophenolic Acid and its 7-O-glucuronide in rats.

Saitoh H, Kobayashi M, Oda M, Nakasato K, Kobayashi M, Tadano K.

Drug Metab Pharmacokinet. 2006 Oct;21(5):406-13.

15.

Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury.

Ysebaert DK, De Greef KE, Vercauteren SR, Verhulst A, Kockx M, Verpooten GA, De Broe ME.

Kidney Int. 2003 Sep;64(3):864-73.

PMID:
12911536
16.

Mycophenolic acid predose concentrations and renal function in a mouse model for progressive renal fibrosis.

Brandhorst G, Brehmer F, Petrova DT, Gross O, Miosge N, Armstrong VW, Oellerich M.

Ther Drug Monit. 2010 Feb;32(1):73-8. doi: 10.1097/FTD.0b013e3181c91fc4.

PMID:
20042922
17.

Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.

de Winter BC, van Gelder T, Sombogaard F, Shaw LM, van Hest RM, Mathot RA.

J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):541-64. doi: 10.1007/s10928-009-9136-6. Epub 2009 Nov 11.

18.

Protein kinase C inhibition ameliorates posttransplantation preservation injury in rat renal transplants.

Fuller TF, Kusch A, Chaykovska L, Catar R, PĆ¼tzer J, Haller M, Troppmair J, Hoff U, Dragun D.

Transplantation. 2012 Oct 15;94(7):679-86. doi: 10.1097/TP.0b013e318265c4d8.

PMID:
22932117
19.
20.

Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure.

Pechman KR, Basile DP, Lund H, Mattson DL.

Am J Physiol Regul Integr Comp Physiol. 2008 Apr;294(4):R1234-9. doi: 10.1152/ajpregu.00821.2007. Epub 2008 Feb 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk